NIOX Group (NIOX) Competitors

NIOX Group (LON:NIOX) and Smith & Nephew (LON:SN) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

Which has more volatility & risk, NIOX or SN?

NIOX Group has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, Smith & Nephew has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500.

Which has preferable valuation and earnings, NIOX or SN?

NIOX Group has higher earnings, but lower revenue than Smith & Nephew. Smith & Nephew is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NIOX Group	£3.53B	8.03	£995.88M	£0.02	2,847.51
Smith & Nephew	£7.08B	1.82	£382.79M	£27.77	42.25

Is NIOX or SN a better dividend stock?

NIOX Group pays an annual dividend of GBX 1 per share and has a dividend yield of 1.4%. Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.5%. NIOX Group pays out 4,126.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Smith & Nephew is clearly the better dividend stock, given its higher yield and lower payout ratio.

Does the media favor NIOX or SN?

In the previous week, Smith & Nephew had 1 more articles in the media than NIOX Group. MarketBeat recorded 1 mentions for Smith & Nephew and 0 mentions for NIOX Group. Smith & Nephew's average media sentiment score of 0.75 beat NIOX Group's score of 0.00 indicating that Smith & Nephew is being referred to more favorably in the news media.

Company	Overall Sentiment
NIOX Group	Neutral
Smith & Nephew	Positive

Do analysts recommend NIOX or SN?

NIOX Group currently has a consensus target price of GBX 90, indicating a potential upside of 30.43%. Smith & Nephew has a consensus target price of GBX 7,840, indicating a potential upside of 568.09%. Given Smith & Nephew's higher possible upside, analysts plainly believe Smith & Nephew is more favorable than NIOX Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Smith & Nephew	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is NIOX or SN more profitable?

NIOX Group has a net margin of 28.21% compared to Smith & Nephew's net margin of 5.41%. NIOX Group's return on equity of 13.29% beat Smith & Nephew's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NIOX Group	28.21%	13.29%	3.95%
Smith & Nephew	5.41%	5.85%	4.51%

Do institutionals and insiders believe in NIOX or SN?

35.2% of NIOX Group shares are held by institutional investors. Comparatively, 62.2% of Smith & Nephew shares are held by institutional investors. 46.7% of NIOX Group shares are held by company insiders. Comparatively, 0.2% of Smith & Nephew shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Smith & Nephew beats NIOX Group on 9 of the 16 factors compared between the two stocks.